Stress Reactivity and Nicotine Addiction Among African American and White Smokers

Sponsor
Medical University of South Carolina (Other)
Overall Status
Recruiting
CT.gov ID
NCT05490251
Collaborator
Virginia Commonwealth University (Other), City of Hope Medical Center (Other)
100
1
26.2
3.8

Study Details

Study Description

Brief Summary

The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cigarette smoking is a leading cause of morbidity and mortality from lung cancer among adults in the US. Stress relief and smoking cessation is the best preventive strategy for reducing lung cancer risk and addressing racial disparities in outcomes. Despite this, racial differences are found among those that make quit attempts. Stress has been found to be related to smoking initiation, maintenance, and relapse. Yet, differences in stress responses have not been examined between African American and white smokers. Therefore, this study will examine racial differences in stress responses and smoking behaviors between African American and white male smokers

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Biological Pathways in Stress Reactivity and Nicotine Addiction Among African American and White Smokers
    Actual Study Start Date :
    Jun 27, 2022
    Anticipated Primary Completion Date :
    Jul 31, 2024
    Anticipated Study Completion Date :
    Aug 31, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Examining racial differences in acute stress responses [Within 1 month following baseline]

      Examine racial differences in acute stress responses using a validated psychological stress challenge called the Trier Social Stress Test (TSST)

    2. Examining changes in daily cortisol patterns according to race [Baseline, 4- and 8 weeks post Trier Social Stress Test laboratory visit]

      Examine racial differences in daily diurnal cortisol slopes to evaluate hypothalamic-pituitary-adrenal-axis dysregulation and acute stress

    3. Examine changes in stress responses and smoking behaviors as it relates to social determinant factors [Baseline, 4- and 8-weeks post Trier Social Stress Test laboratory visit]

      Patients will be administered a survey using validated measures to examine socioeconomic, structural, and psychosocial stressors that impact daily stress and smoking behaviors

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • African American and white males

    • Between the ages of 18-75 years old

    • Smoke at least 5 to 10 cigarettes per day

    Exclusion Criteria:
    • Smokers who have a serious cognitive disorder

    • Have a personal history of lung cancer

    • Personal history of usage of illicit drug and alcohol abuse

    • Enrollment in a smoking cessation treatment program during the past 6 months

    • Current use of a nicotine replacement therapy

    • Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medical University of South Carolina Charleston South Carolina United States 29425

    Sponsors and Collaborators

    • Medical University of South Carolina
    • Virginia Commonwealth University
    • City of Hope Medical Center

    Investigators

    • Principal Investigator: Chanita Hughes-Halbert, PhD, University of Southern California

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Gayenell S. Magwood, Professor, Medical University of South Carolina
    ClinicalTrials.gov Identifier:
    NCT05490251
    Other Study ID Numbers:
    • 00116801
    First Posted:
    Aug 5, 2022
    Last Update Posted:
    Aug 5, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2022